Xu Z - Search Results

1

Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis.

Wang J, Xu J, Gale RP, Xu Z, Li B, Qin T, Zhang Y, Fang L, Zhang H, Pan L, Qu S, Zhang P, Xiao Z. Wang J, et al. Among authors: xu j, xu z. Leuk Res. 2014 Oct;38(10):1207-11. doi: 10.1016/j.leukres.2014.08.006. Epub 2014 Aug 22. Leuk Res. 2014. PMID: 25182689

2

Isochromosome 17q in patients with myelodysplastic syndromes: six new cases.

Xiao Z, Liu S, Yu M, Xu Z, Hao Y. Xiao Z, et al. Among authors: xu z. Haematologica. 2003 Jun;88(6):714-5. Haematologica. 2003. PMID: 12801850 No abstract available.

3

Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia.

Xiao Z, Yang L, Xu Z, Zhang Y, Liu L, Nie L, Li L, Wang J, Hao Y. Xiao Z, et al. Among authors: xu z. Leuk Res. 2008 Aug;32(8):1288-91. doi: 10.1016/j.leukres.2007.10.010. Epub 2007 Nov 26. Leuk Res. 2008. PMID: 18035413

4

[Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia].

Liu L, Yang L, Zhang Y, Xu ZF, Yu MH, Wang JX, Xiao ZJ. Liu L, et al. Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):378-82. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18581889 Chinese.

5

[Preliminary study of diagnosis of patients with myelodysplastic syndromes by routine laboratory parameters].

Li L, Nie L, Yu MH, Zheng YZ, Zhang Y, Xu ZF, Hao YS, Xiao ZJ. Li L, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Sep;29(9):623-8. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19175993 Chinese.

6

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ. Yu MH, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19563026 Chinese.

7

[The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result].

Li L, Nie L, Yu MH, Yu Y, Liu L, Qin TJ, Xu ZF, Zhang Y, Xiao ZJ. Li L, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):313-7. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19799126 Chinese.

8

[Clinical study on regimen cyclophosphamide, Ara-C and topotecan (CAT) in treatment of patients with refractory or relapsed acute myelogenous leukemia].

Qin TJ, Xu ZF, Wang JY, Zhou CL, Xiao ZJ. Qin TJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1342-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19840480 Clinical Trial. Chinese.

9

[Low-dose melphalan therapy for patients with intermediate- to high-risk myelodysplastic syndromes].

Liu L, Qin TJ, Xu ZF, Zhou CL, Zhang Y, Xiao ZJ. Liu L, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Jul;30(7):443-5. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954594 Clinical Trial. Chinese.

10

Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?

Xiao Z, Liu L, Xu Z, Qin T, Zhang Y, Zhang T. Xiao Z, et al. Among authors: xu z. Leuk Lymphoma. 2010 Mar;51(3):549-51. doi: 10.3109/10428190903515200. Leuk Lymphoma. 2010. PMID: 20038270 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,794 results

Search Page

Filters